Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.550
-0.030 (-1.16%)
Sep 5, 2025, 12:26 PM - Market open
Psyence Biomedical Employees
Psyence Biomedical had 12 employees as of March 31, 2025.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
$84,316
Market Cap
1.49M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PBM News
- 8 days ago - Psyence BioMed to Present at the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025 - GlobeNewsWire
- 5 weeks ago - Psyence BioMed's Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production - GlobeNewsWire
- 2 months ago - PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares - GlobeNewsWire
- 2 months ago - PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares - GlobeNewsWire
- 2 months ago - Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025 - Newsfile Corp
- 2 months ago - Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements - Newsfile Corp
- 3 months ago - Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial - Newsfile Corp
- 4 months ago - Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split - Newsfile Corp